Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CCM Duopharma Biotech Bhd Does Not Recommend Dividend


Sunday, 26 May 2013 08:00pm EDT 

CCM Duopharma Biotech Bhd announced that the directors did not recommend any interim dividend for the current quarter ended March 31, 2013. 

Company Quote

3.74
-0.06 -1.58%
27 Mar 2015